Decisions about approving covid-19 vaccines and strategies for their use in the UK must be rapid and transparent, say Azeem Majeed and colleagues, and a sustainable infrastructure should be put in place for delivering covid-19 vaccines to the public
No takes yet. Share an insight, caveat, or question.
Majeed et al. (2022) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: